comparemela.com

Latest Breaking News On - Sphera funds management - Page 7 : comparemela.com

FNY Investment Advisers LLC Invests $100,000 in Gracell Biotechnologies Inc. (NASDAQ:GRCL)

FNY Investment Advisers LLC Invests $100,000 in Gracell Biotechnologies Inc. (NASDAQ:GRCL)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Stifel-nicolaus
Sphera-funds-management
Vivo-capital
Capital-group-international-inc
Wells-fargo-company
Gracell-biotechnologies-inc
Venture-partners-investment-advisor
Nasdaq
Fny-investment-advisers
Gracell-biotechnologies
Free-report
Funds-management

Fusion Pharmaceuticals (NASDAQ:FUSN) Rating Lowered to Market Perform at William Blair

William Blair cut shares of Fusion Pharmaceuticals (NASDAQ:FUSN – Free Report) from an outperform rating to a market perform rating in a report published on Tuesday, MarketBeat.com reports. William Blair also issued estimates for Fusion Pharmaceuticals’ Q1 2025 earnings at ($0.45) EPS, Q2 2025 earnings at ($0.46) EPS, Q3 2025 earnings at ($0.47) EPS and […]

United-states
Wellington
New-zealand-general
New-zealand
Canada
William-blair
Raymond-james
Analyst-recommendations-for-fusion-pharmaceuticals
Fusion-pharmaceuticals
Sphera-funds-management
News-ratings-for-fusion-pharmaceuticals-daily
Perceptive-advisors

Adage Capital Partners GP L.L.C. Acquires New Holdings in Gracell Biotechnologies Inc. (NASDAQ:GRCL)

Adage Capital Partners GP L.L.C. bought a new position in Gracell Biotechnologies Inc. (NASDAQ:GRCL – Free Report) in the 3rd quarter, HoldingsChannel reports. The fund bought 850,000 shares of the company’s stock, valued at approximately $2,448,000. Other institutional investors and hedge funds have also recently bought and sold shares of the company. Vivo Capital LLC […]

Stifel-nicolaus
Piper-sandler
Vivo-capital
Capital-group-international-inc
Nasdaq
Venture-partners-investment-advisor
Wells-fargo-company
Sphera-funds-management
Cantor-fitzgerald
Gracell-biotechnologies-inc
Adage-capital-partners
Gracell-biotechnologies

Dyne Therapeutics, Inc. (NASDAQ:DYN) CEO Sells $234,873.10 in Stock

Dyne Therapeutics, Inc. (NASDAQ:DYN) CEO Sells $234,873.10 in Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Canada
Stifel-nicolaus
Joshuat-brumm
Zurcher-kantonalbank-zurich-cantonalbank
Ameritas-investment-partners-inc
Royal-bank
Dyne-therapeutics-inc
Nasdaq
Sphera-funds-management
Allspring-global-investments-holdings
Dyne-therapeutics

Q1 2024 EPS Estimates for Elevation Oncology, Inc. (NASDAQ:ELEV) Increased by Analyst

Elevation Oncology, Inc. (NASDAQ:ELEV – Free Report) – Investment analysts at HC Wainwright upped their Q1 2024 EPS estimates for Elevation Oncology in a research report issued to clients and investors on Thursday, March 7th. HC Wainwright analyst S. Ramakanth now forecasts that the company will earn ($0.20) per share for the quarter, up from […]

Sphera-funds-management
Elevation-oncology-company-profile
Bio-partners
Citadel-advisors
Elevation-oncology-inc
Nasdaq
Elevation-oncology
Free-report
Point-capital-management
Funds-management
Hudson-bay-capital-management

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.